Zentynel Ventures
Seed → Series A
Their stated focus (public profile)
Zentynel is Latin America's first venture capital fund specialized in biotechnology, investing across the full value chain with a One Health perspective that recognizes the interconnection of human, animal, and environmental health. The fund focuses on early-stage ventures with global ambition and strong ties to Latin America, targeting human and animal health (pharmaceuticals, vaccines, diagnostics, medical devices), digital health and AI-driven platforms, and agri-tech, food technology, and environmental biotech solutions. Fund II is a $50M vehicle designed to bridge the capital gap in the region and generate positive impact across health and sustainability.
Stages: Seed → Series A
Sectors: Life sciences, Healthtech, Agtech, Foodtech, Medtech
Check size: US$1 a US$2 millones
On file: 7 partners on record · 17 companies on record
Website: zentynel.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.